U.S. federal trademark · Serial No. 98247335 · Reg. No. UK00003919559
Research and development services in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; consulting services for others in the field of design planning and implementation project management of clinical trials in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.